Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -1.324% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) COC(=O)c1ccc(C2C(C(=O)Nc3ccccc3C)=C(C)Nc3ncnn32)cc1
b) CC(C)CCNC(=O)CC1Nc2c3ccccc3nc(=S)n2C1=O
Answer: a. COC(=O)c1ccc(C2C(C(=O)Nc3ccccc3C)=C(C)Nc3ncnn32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(C2C(C(=O)Nc3ccccc3C)=C(C)Nc3ncnn32)cc1
COC(=O)c1ccc(C2C(C(=O)Nc3ccccc3C)=C(C)Nc3ncnn32)cc1
methyl 4-[5-methyl-6-[(2-methylphenyl)carbamoyl]-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]benzoate